Singular Genomics Systems: Josh Stahl, Drew Spaventa, Jason Myers

Josh Stahl has been appointed as CEO of Singular Genomics Systems following the firm's acquisition by Deerfield Management Company. He succeeds former CEO and Cofounder Drew Spaventa, who will continue to serve on the board of directors and become a special advisor to the CEO. Stahl and Jason Myers will join Singular's board of directors.